Harvard Bioscience Inc (NAS:HBIO)
$ 2.82 0.43 (17.99%) Market Cap: 122.98 Mil Enterprise Value: 160.39 Mil PE Ratio: 0 PB Ratio: 1.83 GF Score: 58/100

Q4 2023 Harvard Bioscience Inc Earnings Call Transcript

Mar 07, 2024 / 01:00PM GMT
Release Date Price: $4.51 (+9.73%)
Operator

Good morning and thank you for standing by, and welcome to Harvard Bioscience, Inc. fourth quarter 2023 earnings conference call. (Operator Instructions) Please note that today's conference is being recorded.

I will now hand the conference over to your speaker host, David Sirois, Director of SEC Reporting. Please go ahead.

David Sirois
Harvard Bioscience, Inc. - Director of Corporate Accounting & SEC Reporting

Thank you, Olivia, and good morning, everyone. Thank you for joining the Harvard Bioscience fourth quarter 2023 earnings conference call. Before we begin, I would like to suggest that you take a moment to download a copy of a presentation that will be referred to during this call. The file is entitled Q4 2023 HBIO quarterly earnings presentation and is located in the Investor Overview, Events and Presentations section of our website.

Leading the call today will be Jim Green, Chairman of the Board, President and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer.

Before I turn the call over to Jim, I will

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot